Novo A
Investor profile
Investment firm
Novo A has backed 5 European tech companies across 9 funding rounds between 2004 and 2016, joining rounds totalling €470M. Most active in Healthtech. Data as of Nov 2026.
Deals
9
distinct rounds
Companies
5
backed
Active span
2004–2016
13 yrs
Total round €
€470M
sum of rounds joined
Deals by year
distinct rounds / yearNovo A — deals by year — interactive chart.
Data table
| Novo A — deals by year | |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
Top sectors
by dealsNovo A — top sectors — interactive chart.
Data table
| Novo A — top sectors | |
|---|---|
| Healthtech | 9 |
Stages
by dealsNovo A — stages — interactive chart.
Data table
| Novo A — stages | |
|---|---|
| Growth/Late | 2 |
| Series A | 2 |
| Series C | 2 |
| Series D+ | 2 |
| Debt | 1 |
Countries
by dealsNovo A — countries — interactive chart.
Data table
| Novo A — countries | |
|---|---|
| Denmark | 5 |
| UK | 3 |
| Netherlands | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Symphogen | Denmark | 5 | €249M |
| Adaptimmune | UK | 1 | €79M |
| Merus | Netherlands | 1 | €73M |
| F2G | UK | 1 | €55M |
| NeRRe Therapeutics | UK | 1 | €14M |